Clinical trial
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients
NCT05981326 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients
- Lead sponsor
- Institut Cancerologie de l'Ouest
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 31, 2023
- Completion date
- April 30, 2033
- Enrollment
- 300 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer